Heart failure: an update from the last years and a look at the near future
Abstract In the last years, major progress occurred in heart failure (HF) management. Quadruple therapy is now mandatory for all the patients with HF with reduced ejection fraction. Whilst verciguat is becoming available across several countries, omecamtiv mecarbil is waiting to be released for clin...
| Main Authors: | , , , , , , , , |
|---|---|
| פורמט: | Article |
| שפה: | English |
| יצא לאור: |
Wiley
2022-12-01
|
| סדרה: | ESC Heart Failure |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1002/ehf2.14257 |